New Study Reveals Best Antithrombotic Regimen for Atrial Fibrillation Post-ACS/PCI: Apixaban and P2Y12 Inhibitor Shine Medha Baranwal15 Nov 2024 9:00 AM ISTUSA: A new study from the AUGUSTUS trial has provided new insights into the most effective antithrombotic strategies for patients with atrial...
No difference in ischaemic events if aspirin interrupted or continued among patients with PCI undergoing non-cardiac surgery: ESC 2024 Dr. Kamal Kant Kohli4 Sept 2024 8:30 AM ISTAmong patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with...
Treatment of STEMI patients with P2Y12 Inhibitor before hospitalization may not improve MACE Aditi16 Jan 2024 9:00 PM ISTPre-treating STEMI (ST-segment elevation myocardial infarction) patients with P2Y12 inhibitors before hospitalisation does not reduce the risk of...
DAPT de-escalation, short-term DAPT, best strategies for patients with acute coronary syndromes Medha Baranwal12 Sept 2023 10:15 AM ISTUSA: A recent network meta-analysis published in AHA Circulation Cardiovascular Interventions by Kuno T and colleagues has shed light on the optimal...
P2Y12 inhibitor monotherapy better than aspirin for secondary prevention in CAD patients, finds Meta-analysis Dr. Kamal Kant Kohli19 July 2023 11:15 AM ISTItaly: Recent research has demonstrated superior efficacy and similar overall safety of P2Y12 inhibitor monotherapy over aspirin monotherapy for...
Asundexian promising oral anticoagulant in post-myocardial infarction patients Dr. Kamal Kant Kohli15 Sept 2022 8:00 PM ISTResearchers have found in a new study that Asundexian was a promising oral anticoagulant in post-myocardial infarction patients.Asundexian 50 mg...
P2Y12 inhibitor monotherapy 3 months after PCI sufficient to lower CV mortality: BMJ Medha Baranwal21 Jun 2021 10:00 AM ISTBern, Switzerland: The use of P2Y12 inhibitor monotherapy versus DAPT is associated with a similar risk of stroke, myocardial infarction, and death,...
Dropping Aspirin and continuing with P2Y12 inhibitors safe 1 month after PCI: Study Medha Baranwal7 July 2020 11:57 AM ISTBoston, MA: Aspirin discontinuation 1-3 months after PCI and continuing with P2Y12 inhibitor monotherapy reduces bleeding risk, according to a...
